Anti-GPRL1/ GLIPR1L1/ ALKN2972 monoclonal antibody

Anti-GPRL1/ GLIPR1L1/ ALKN2972 antibody for FACS & in-vivo assay

Target products collectionGo to GLIPR1L1/GLIPR1L1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2398-Ab-1/ GM-Tg-hg-MP2398-Ab-2Anti-Human GLIPR1L1 monoclonal antibodyHuman
GM-Tg-rg-MP2398-Ab-1/ GM-Tg-rg-MP2398-Ab-2Anti-Rat GLIPR1L1 monoclonal antibodyRat
GM-Tg-mg-MP2398-Ab-1/ GM-Tg-mg-MP2398-Ab-2Anti-Mouse GLIPR1L1 monoclonal antibodyMouse
GM-Tg-cynog-MP2398-Ab-1/ GM-Tg-cynog-MP2398-Ab-2Anti-Cynomolgus/ Rhesus macaque GLIPR1L1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2398-Ab-1/ GM-Tg-felg-MP2398-Ab-2Anti-Feline GLIPR1L1 monoclonal antibodyFeline
GM-Tg-cang-MP2398-Ab-1/ GM-Tg-cang-MP2398-Ab-2Anti-Canine GLIPR1L1 monoclonal antibodyCanine
GM-Tg-bovg-MP2398-Ab-1/ GM-Tg-bovg-MP2398-Ab-2Anti-Bovine GLIPR1L1 monoclonal antibodyBovine
GM-Tg-equg-MP2398-Ab-1/ GM-Tg-equg-MP2398-Ab-2Anti-Equine GLIPR1L1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2398-Ab-1/ GM-Tg-hg-MP2398-Ab-2; GM-Tg-rg-MP2398-Ab-1/ GM-Tg-rg-MP2398-Ab-2;
GM-Tg-mg-MP2398-Ab-1/ GM-Tg-mg-MP2398-Ab-2; GM-Tg-cynog-MP2398-Ab-1/ GM-Tg-cynog-MP2398-Ab-2;
GM-Tg-felg-MP2398-Ab-1/ GM-Tg-felg-MP2398-Ab-2; GM-Tg-cang-MP2398-Ab-1/ GM-Tg-cang-MP2398-Ab-2;
GM-Tg-bovg-MP2398-Ab-1/ GM-Tg-bovg-MP2398-Ab-2; GM-Tg-equg-MP2398-Ab-1/ GM-Tg-equg-MP2398-Ab-2
Products NameAnti-GLIPR1L1 monoclonal antibody
Formatmab
Target NameGLIPR1L1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GLIPR1L1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GPRL1/ GLIPR1L1/ ALKN2972 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2398
    Target NameGLIPR1L1
    Gene ID256710,69286,503139,718901,610032,101087075,615034,100058150
    Gene Symbol and Synonyms1700011E04Rik,ALKN2972,GLIPR1L1,PRO7434,RGD1563000
    Uniprot AccessionQ6UWM5,Q32LB5
    Uniprot Entry NameGPRL1_HUMAN,GPRL1_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000173401
    Target ClassificationN/A

    The target: GLIPR1L1, gene name: GLIPR1L1, also named as ALKN2972, PRO7434. Predicted to be involved in single fertilization. Predicted to act upstream of or within binding activity of sperm to zona pellucida. Predicted to be located in sperm connecting piece. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.